In addition, it has been reported that HCG11 is abnormally expressed in various tumors and can serve as a key regulatory factor for various cancers such as PCa 65, non-small cell lung cancer 66, and hepatocellular carcinoma 67. Here, HCG11 is linked to posterior cortical atrophy.